Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-024534-38Phase 2Terminated
Phase 2, open-label trial of dabigatran in heart failure (HF) and Mechanical Circulatory Support (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Major and minor thromboembolic adverse events. Started Jun 2011; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-024534-38.